Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
391 studies found for:    Atrial Fibrillation and Stroke
Show Display Options
Rank Status Study
21 Unknown  "Cryptogenic Stroke and Atrial Fibrillation Detection Through Implantable Loop Recorder (ILR)"
Conditions: Atrial Fibrillation;   Stroke
Intervention:
22 Active, not recruiting Atrial Fibrillation as a Cause of Stroke and Intracranial Hemorrhage Study (The FibStroke Study)
Conditions: Stroke;   Transient Ischemic Attacks;   Intracranial Hemorrhage;   Atrial Fibrillation
Intervention:
23 Completed Occult Paroxysmal Atrial Fibrillation in Patients With Non-cardioembolic Ischemic Stroke of Determined Mechanism
Conditions: Atrial Fibrillation;   Stroke
Intervention:
24 Completed
Has Results
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
Conditions: Atrial Fibrillation;   Atrial Flutter
Interventions: Drug: warfarin;   Drug: apixaban
25 Recruiting Evaluation of Effectiveness and Safety of Xa Inhibitor for the Prevention of Stroke And Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-valvular Atrial Fibrillation
Condition: Non-valvular Atrial Fibrillation
Intervention:
26 Active, not recruiting Minimally Invasive Surgical Treatment Versus Medical Management for Stroke Patients With Atrial Fibrillation
Conditions: Atrial Fibrillation;   Stroke
Interventions: Procedure: Minimally Invasive Surgery;   Other: Medical therapy
27 Recruiting Detection of Atrial Fibrillation in Patients With Recent Stroke or TIA: Validity of Automated Loop-recording (Rtest) Compared to Holter Recording and Predictive Value of Short Runs of Atrial Fibrillation and an Excess Supraventricular Extra Systoles for a New Stroke
Conditions: Stroke;   Ischaemic Stroke;   Atrial Fibrillation;   Supra Ventricular Extra Systoles
Intervention:
28 Recruiting HEart and BRain Interfaces in Acute Ischemic Stroke
Conditions: Stroke;   Atrial Fibrillation
Intervention:
29 Recruiting China Atrial Fibrillation Screening in Acute Ischemic Stroke Patients
Conditions: Atrial Fibrillation;   Stroke
Intervention:
30 Recruiting Atrial Fibrillation Detected by Continuous ECG Monitoring
Conditions: Atrial Fibrillation;   Stroke;   Hypertension;   Diabetes
Intervention: Device: LOOP recorder (Medtronic LINQ device)
31 Recruiting The Secondary Prevention of Nonvalvular Atrial Fibrillation Patients With an Initial Cardioembolic Stroke
Conditions: Cardioembolic Stroke;   Atrial Fibrillation
Interventions: Drug: aspirin plus hirudin;   Drug: Warfarin
32 Completed
Has Results
Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Warfarin;   Drug: Rivaroxaban placebo;   Drug: Warfarin placebo
33 Not yet recruiting Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: Apixaban;   Drug: aspirin
34 Active, not recruiting Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
35 Recruiting Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia
Condition: Atrial Fibrillation
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
36 Recruiting Evaluation of 5 Days Holter and 30 Days Thumb-ECG for Detection of Atrial Fibrillation in Stroke Patients
Conditions: Atrial Fibrillation;   Stroke
Intervention: Device: Holter monitoring and Thumb ECG
37 Recruiting Stroke Prevention and Rhythm Interventions in Atrial Fibrillation
Condition: Cardiovascular Diseases
Intervention:
38 Recruiting Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA Region
Condition: Atrial Fibrillation
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
39 Completed
Has Results
Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion
Condition: Atrial Fibrillation
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Vitamin K antagonist (VKA)
40 Active, not recruiting 30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event
Conditions: Stroke;   Transient Ischemic Attack;   Atrial Fibrillation;   Atrial Flutter
Interventions: Device: a 30-day ambulatory cardiac event monitor;   Device: 24-hour Holter

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years